Loss of Aryl Hydrocarbon Receptor Favors
K-RasG12D
NSCLC
aryl hydrocarbon receptor
lung carcinogenesis
lung stem cells
organoids
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Aug 2021
13 Aug 2021
Historique:
received:
29
07
2021
revised:
09
08
2021
accepted:
10
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Non-small cell lung adenocarcinoma (NSCLC) bearing
Identifiants
pubmed: 34439225
pii: cancers13164071
doi: 10.3390/cancers13164071
pmc: PMC8394265
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Spanish Ministry of Economy and Competitiveness
ID : SAF2017-82597-R
Organisme : Spanish Ministry of Economy and Competitiveness
ID : PID2020-114846RB-I00
Organisme : Junta de Extremadura
ID : GR18006
Organisme : Junta de Extremadura
ID : IB160210
Organisme : Junta de Extremadura
ID : IB20014
Références
Mol Cancer Res. 2009 Mar;7(3):330-8
pubmed: 19276181
Nat Commun. 2019 Sep 13;10(1):4190
pubmed: 31519898
J Thorac Oncol. 2019 May;14(5):876-889
pubmed: 30735816
Sci Rep. 2016 Feb 05;6:20113
pubmed: 26846300
Science. 1995 May 5;268(5211):722-6
pubmed: 7732381
Nature. 2014 Mar 13;507(7491):190-4
pubmed: 24499815
Lung Cancer. 2003 Dec;42(3):255-61
pubmed: 14644512
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Am J Cancer Res. 2018 Jul 01;8(7):1214-1227
pubmed: 30094095
J Clin Invest. 2012 Dec;122(12):4388-400
pubmed: 23143308
Lung Cancer. 2018 Oct;124:53-64
pubmed: 30268480
Curr Opin Toxicol. 2017 Feb;2:1-7
pubmed: 28920102
Nat Genet. 2006 Mar;38(3):331-6
pubmed: 16474405
Nature. 2017 May 18;545(7654):355-359
pubmed: 28489818
Arch Toxicol. 2017 Jul;91(7):2497-2513
pubmed: 28508231
Stem Cell Res. 2017 Dec;25:61-71
pubmed: 29107893
iScience. 2018 Jun 29;4:44-63
pubmed: 30240752
Nat Rev Dis Primers. 2015 May 21;1:15009
pubmed: 27188576
Open Biol. 2016 Dec;6(12):
pubmed: 28003471
Int J Mol Sci. 2020 Dec 31;22(1):
pubmed: 33396563
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
Annu Rev Cell Dev Biol. 2011;27:493-512
pubmed: 21639799
Lung Cancer. 2019 Jul;133:144-150
pubmed: 31200821
Cancer Lett. 2016 Jul 1;376(2):211-7
pubmed: 27060206
Genome Biol. 2017 Dec 20;18(1):236
pubmed: 29262847
PLoS Biol. 2016 Nov 23;14(11):e1002581
pubmed: 27880766
Cancer Treat Rev. 2020 Apr;85:101978
pubmed: 32062493
Pharmacol Ther. 2018 May;185:50-63
pubmed: 29258844
Toxicol Pathol. 2003 Jan-Feb;31(1):22-30
pubmed: 12597446
Sci Rep. 2017 Sep 5;7(1):10420
pubmed: 28874739
Oncogenesis. 2020 Nov 19;9(11):102
pubmed: 33214553
EMBO J. 2013 Oct 16;32(20):2708-21
pubmed: 24045232
Development. 2017 Mar 15;144(6):938-941
pubmed: 28292837
Front Cell Dev Biol. 2016 May 11;4:45
pubmed: 27243009
Stem Cells. 2016 Dec;34(12):2825-2839
pubmed: 27374890
N Engl J Med. 2008 Sep 25;359(13):1367-80
pubmed: 18815398
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
Exp Cell Res. 2020 Nov 1;396(1):112288
pubmed: 32941808
Anticancer Res. 2009 May;29(5):1817-22
pubmed: 19443410
Oncotarget. 2017 Jul 18;8(29):48248-48252
pubmed: 28525386
J Clin Invest. 2013 Jul;123(7):3025-36
pubmed: 23921127
Oncotarget. 2017 Dec 2;8(67):110877-110889
pubmed: 29340023
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062